![[up]](/style/images/multi_up.png)
Up a levelGroup by: Item Type | Date
Jump to: Journal article
Number of items: 2.
Journal article
Frost, Nikolaj; Christopoulos, Petros; Kauffmann-Guerrero, Diego; Stratmann, Jan; Riedel, Richard; Schaefer, Monica; Alt, Jürgen; Gutz, Sylvia; Christoph, Daniel C.; Laack, Eckart; Faehling, Martin; Fischer, Richard; Fenchel, Klaus; Haen, Sebastian; Heukamp, Lukas; Schulz, Christian und Griesinger, Frank
(2021):
Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access program.
In: Therapeutic Advances in Medical Oncology, Vol. 13, 1758835920980558
Saalfeld, Felix C.; Wenzel, Carina; Christopoulos, Petros; Merkelbach-Bruse, Sabine; Reissig, Timm M.; Lassmann, Silke; Thiel, Sebastian; Stratmann, Jan A.; Marienfeld, Ralf; Berger, Johannes; Desuki, Alexander; Velthaus, Janna-Lisa; Kauffmann-Guerrero, Diego; Stenzinger, Albrecht; Michels, Sebastian; Herold, Thomas; Kramer, Michael; Herold, Sylvia; Tufman, Amanda; Loges, Sonja; Alt, Jürgen; Joosten, Maria; Schmidtke-Schrezenmeier, Gerlinde; Sebastian, Martin; Stephan-Falkenau, Susann; Waller, Cornelius F.; Wiesweg, Marcel; Wolf, Jürgen; Thomas, Michael; Aust, Daniela E. und Wermke, Martin
(2021):
Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations.
In: Journal of Thoracic Oncology, Vol. 16, No. 11: pp. 1952-1958